Literature DB >> 25817253

VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.

Ran Antes, Shiran Salomon-Zimri, Susanne C Beck, Marina Garcia Garrido, Tami Livnat, Idit Maharshak, Tamar Kadar, Mathias Seeliger, Dov Weinberger, Daniel M Michaelson1.   

Abstract

Apolipoprotein E4 (apoE4), the most prevalent genetic risk factor for Alzheimer's disease (AD), is associated with neuronal and vascular impairments. Recent findings suggest that retina of apoE4 mice have synaptic and functional impairments. We presently investigated the effects of apoE4 on retinal and choroidal vasculature and the possible role of VEGF in these effects. There were no histological differences between the retinal and choroidal vasculatures of naïve apoE3 and apoE4 mice. In contrast, laserdriven choroidal injury induced higher levels of choroidal neovascularization (CNV) in apoE4 than in apoE3 mice. These effects were associated with an inflammatory response and with activation of the Muller cells and asrocytic markers gluthatione synthetase and GFAP, all of which were more pronounced in the apoE4 mice. CNV also induced a transient increase in the levels of the synaptic markers synaptophysin and PSD95 which were however similar in the apoE4 and apoE3 naive mice. Retinal and choroidal VEGF and apoE levels were lower in naïve apoE4 than in corresponding apoE3 mice. In contrast, VEGF and apoE levels rose more pronouncedly following laser injury in the apoE4 than in apoE3 mice. Taken together, these findings suggest that the apoE4-induced retinal impairments, under basal conditions, may be related to reduced VEGF levels in the eyes of these mice. The hyper-neovascularization in the apoE4 mice might be driven by increased inflammation and the associated surge in VEGF following injury. Retinal and choroidal VEGF and apoE levels were lower in naïve apoE4 than in corresponding apoE3 mice. In contrast, VEGF and apoE levels rose more pronouncedly following laser injury in the apoE4 than in apoE3 mice. Taken together, these findings suggest that the apoE4-induced retinal impairments, under basal conditions, may be related to reduced VEGF levels in the eyes of these mice. The hyper-neovascularization in the apoE4 mice might be driven by increased inflammation and the associated surge in VEGF following injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25817253     DOI: 10.2174/1567205012666150325182504

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  8 in total

1.  Retinal Vascular Study Using OCTA in Subjects at High Genetic Risk of Developing Alzheimer's Disease and Cardiovascular Risk Factors.

Authors:  Inés López-Cuenca; Elena Salobrar-García; Lidia Sánchez-Puebla; Eva Espejel; Lucía García Del Arco; Pilar Rojas; Lorena Elvira-Hurtado; José A Fernández-Albarral; Federico Ramírez-Toraño; Ana Barabash; Juan J Salazar; José M Ramírez; Rosa de Hoz; Ana I Ramírez
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

Review 2.  Ocular indicators of Alzheimer's: exploring disease in the retina.

Authors:  Nadav J Hart; Yosef Koronyo; Keith L Black; Maya Koronyo-Hamaoui
Journal:  Acta Neuropathol       Date:  2016-09-19       Impact factor: 17.088

3.  Computational Approach to Investigating Key GO Terms and KEGG Pathways Associated with CNV.

Authors:  YuanYuan Luo; Yan Yan; Shiqi Zhang; Zhen Li
Journal:  Biomed Res Int       Date:  2018-04-11       Impact factor: 3.411

4.  Changes in retinal microvasculature and retinal layer thickness in association with apolipoprotein E genotype in Alzheimer's disease.

Authors:  Joo Youn Shin; Eun Young Choi; Min Kim; Hyung Keun Lee; Suk Ho Byeon
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

5.  Thicker macula in asymptomatic APOE Ɛ4 middle-aged adults at high AD risk.

Authors:  Ygal Rotenstreich; Inbal Sharvit-Ginon; Ifat Sher; Ofira Zloto; Ido Didi Fabian; Amir Abd-Elkader; Aron Weller; Anthony Heymann; Michal Schnaider Beeri; Ramit Ravona-Springer
Journal:  Alzheimers Dement (Amst)       Date:  2022-02-09

6.  Dementia risk and dynamic response to exercise: A non-randomized clinical trial.

Authors:  Eric D Vidoni; Jill K Morris; Jacqueline A Palmer; Yanming Li; Dreu White; Paul J Kueck; Casey S John; Robyn A Honea; Rebecca J Lepping; Phil Lee; Jonathan D Mahnken; Laura E Martin; Sandra A Billinger
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

7.  Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia.

Authors:  Haoshen Shi; Zhuoran Yin; Yosef Koronyo; Dieu-Trang Fuchs; Julia Sheyn; Miyah R Davis; Jered W Wilson; Milica A Margeta; Kristen M Pitts; Shawn Herron; Seiko Ikezu; Tsuneya Ikezu; Stuart L Graham; Vivek K Gupta; Keith L Black; Mehdi Mirzaei; Oleg Butovsky; Maya Koronyo-Hamaoui
Journal:  Acta Neuropathol Commun       Date:  2022-09-08       Impact factor: 7.578

8.  Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.

Authors:  Nina Schultz; Elin Byman; Malin Wennström
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.